• Fortescue shares just hit a 52-week low. Could $16 be next?

    An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements

    Fortescue Ltd (ASX: FMG) shares are back at levels investors have not seen for a year.

    The iron ore giant is down 0.60% to $16.57 during Monday trade, putting the stock right on its 52-week low.

    That extends what has been a rough run in 2026, with Fortescue shares now down around 25% since the start of the year.

    The stock was trading as high as $23.13 on 14 May, so the decline from those levels is now close to 30%.

    So, just how much further could Fortescue shares fall?

    Let’s take a closer look.

    Why are Fortescue shares struggling?

    Fortescue’s FY26 result actually had a few decent numbers in it.

    Revenue rose 9% to US$16.97 billion, helped by higher shipments and iron ore prices, while both operating cash flow and free cash flow moved higher.

    However, statutory net profit fell 15% to US$2.86 billion, while the final fully-franked dividend dropped to 46 cents per share from 60 cents a year earlier.

    There are a few other concerns hanging over the stock as well.

    Fortescue is expecting higher spending in FY27, while the iron ore outlook remains difficult to read with China’s property sector still weak.

    Could the shares fall below $16?

    Looking at the latest broker targets, I wouldn’t rule it out.

    TipRanks shows 11 recent analyst ratings on Fortescue, with 2 buys, 6 holds, and 3 sells.

    The average 12-month price target is $17.91, which is around 8% above the current share price.

    But some analysts are much more cautious.

    The lowest target is $15.40 from Jarden, with Morgan Stanley close behind at $15.45. Jefferies has a $16 target, which is already below where the shares are trading today.

    At the other end, RBC Capital, Macquarie, and BMO Capital each have $20 targets, around 21% above Fortescue’s current price.

    What would I watch from here?

    Iron ore prices are probably the first thing I’d be watching.

    Fortescue is still very heavily exposed to the commodity, so any further weakness could put more pressure on earnings and the share price.

    I’d also keep an eye on the current 52-week low of around $16.57.

    If the shares break below that level, the $15.50 area starts to come into play, especially with Jarden and Morgan Stanley already sitting around there with their price targets.

    Fortescue shares are obviously a lot cheaper than they were a few months ago, but I’m not convinced the fall is over just yet.

    The post Fortescue shares just hit a 52-week low. Could $16 be next? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Fortescue right now?

    Before you buy Fortescue shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Fortescue wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Jefferies Financial Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 3 top Vanguard ETFs I’d buy with $3,000

    A glass outdoors with a sign with ETFs written on it, as well as coins and a growing plant.

    Having $3,000 ready to invest opens up plenty of possibilities on the ASX.

    For me, exchange-traded funds (ETFs) would be worth considering because they can put that money to work across a large number of businesses straight away.

    These three Vanguard ETFs would all be on my shortlist.

    Vanguard Diversified High Growth Index ETF (ASX: VDHG)

    For someone wanting to keep things simple, the VDHG ETF could be a strong option.

    The fund is effectively a ready-made investment portfolio. Around 90% is allocated to growth assets such as Australian and international shares, with the remainder invested in defensive assets such as bonds.

    That gives investors exposure to thousands of securities across numerous markets without having to decide how much money to allocate to each one.

    Vanguard also takes care of rebalancing the portfolio over time.

    I think that makes the Vanguard Diversified High Growth Index ETF particularly interesting for an investor who wants to buy one ETF, keep adding to it, and largely leave the portfolio management to Vanguard.

    Vanguard Global Technology Index ETF (ASX: VTEK)

    Investors looking for stronger growth exposure might prefer the VTEK ETF.

    This fund invests in hundreds of technology stocks from developed and emerging markets.

    Its holdings include businesses such as Nvidia, Apple, Microsoft, Taiwan Semiconductor Manufacturing Company, and ASML Holding.

    That gives investors exposure to several areas I expect to keep attracting significant investment over the coming decade, including artificial intelligence, semiconductors, cloud computing, and software.

    Of course, concentrating in one sector would bring more risk than choosing a broadly diversified ETF.

    But for someone comfortable with a higher level of volatility and looking for long-term growth, I think this Vanguard ETF is a top option.

    Vanguard S&P 500 US Shares Index ETF (ASX: V500)

    The V500 ETF is another Vanguard fund that I would buy.

    It tracks the S&P 500 Index, providing exposure to around 500 of the largest companies listed in the United States.

    That includes technology businesses, but also major companies across healthcare, financial services, consumer products, industrials, and many other industries.

    I like this because investors can participate in the growth of corporate America without relying on a handful of individual stock picks.

    The ETF also has a low management fee, which can become increasingly valuable over a long holding period.

    For someone wanting to put money behind US shares, I think the Vanguard S&P 500 US Shares Index ETF could make a lot of sense.

    Foolish takeaway

    I think all three Vanguard ETFs offer something worth considering for a long-term investor.

    Which one I chose would depend on what I already owned and where I wanted more exposure.

    With $3,000 available, I would be comfortable putting the money into one of these ETFs or spreading it across more than one. The important thing for me would be choosing the opportunity that best complemented the rest of my investments.

    The post 3 top Vanguard ETFs I’d buy with $3,000 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Vanguard S&P 500 Us Shares Index ETF right now?

    Before you buy Vanguard S&P 500 Us Shares Index ETF shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Vanguard S&P 500 Us Shares Index ETF wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ASML, Apple, Microsoft, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool Australia has recommended ASML, Apple, Microsoft, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Guess which ASX stock is rocketing 10% today?

    Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.

    One small-cap ASX stock is giving shareholders something to smile about on Monday.

    Titomic Ltd (ASX: TTT) shares are up 10.87% to 12.8 cents after the company announced a new defence contract before the market opened.

    That puts Titomic’s market value at around $228 million.

    It comes after a difficult stretch for shareholders, with the stock still down around 47% in 2026 and 50% over the past 12 months.

    So, what was in this morning’s release?

    A US$5 million contract

    Titomic revealed that its US subsidiary has been awarded a US$5 million contract by the US Air Force.

    The company will supply, integrate and commission one of its TKF 1000 cold spray systems at Tinker Air Force Base in Oklahoma.

    The system can be used for things such as component repair, restoring worn parts, corrosion protection and additive manufacturing.

    Titomic said the contract places its technology inside one of the largest US Air Force maintenance and repair facilities in the country.

    Delivery is scheduled for the third quarter of 2027, with revenue to be recognised as the company completes different stages of the contract.

    More orders are starting to come through

    It’s not like this deal hasn’t arrived completely out of the blue.

    Titomic has been spending the past few years trying to turn trials and qualification work into commercial orders.

    Just recently, it announced a number of US orders worth more than $750,000 across the aerospace, defence, space, energy and oil and gas industries.

    The company has also expanded its Huntsville facility as it builds manufacturing capacity in the United States.

    However, there’s still plenty of work ahead.

    Titomic is still a loss-making company, and earlier this month it raised $16.5 million through a share placement at 13 cents apiece.

    Interestingly, even after today’s rally, the shares are still trading just below that placement price.

    How high could the shares go?

    There is certainly a big gap between the current share price and some broker targets.

    TipRanks shows two recent analyst ratings.

    Bell Potter has a buy rating and 46 cent price target, while Ord Minnett has a hold rating and 18 cent target.

    That gives an average target of 32 cents, or about 150% above where the stock stands today.

    On the other hand, Morningstar is far more conservative, with a fair value estimate of 14.8 cents.

    This just shows how divided analysts remain on the stock.

    Nonetheless, if Titomic can keep winning big defence contracts, those higher targets could become a little more realistic.

    The post Guess which ASX stock is rocketing 10% today? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Titomic right now?

    Before you buy Titomic shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Titomic wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • The ‘key difference’ between the tech bubble of 2000 and today: strategist

  • Stocks on the move: Moderna faces vaccine hurdle, Tesla falls on growth concerns

  • Heron Therapeutics’ (NASDAQ:HRTX) Stock Price Has Reduced48% In The Past Five Years

  • Connecticut General Life Insurance Company — Moody’s announces completion of a periodic review of ratings of Cigna Corporation